These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18278077)

  • 1. Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond.
    Ellis CJ; Hamer AW
    N Z Med J; 2008 Feb; 121(1269):5-10. PubMed ID: 18278077
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
    Stewart RA; North FM; Sharples KJ; Simes RJ; Tonkin AM; White HD;
    N Z Med J; 2008 Feb; 121(1269):11-23. PubMed ID: 18278078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with statins for the reduction of cardiovascular risk].
    Chiariello M
    Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779
    [No Abstract]   [Full Text] [Related]  

  • 4. The sorry saga of the statins in New Zealand--pharmacopolitics versus patient care.
    Begg E; Sidwell A; Gardiner S; Nicholls G; Scott R
    N Z Med J; 2003 Mar; 116(1170):U360. PubMed ID: 12658318
    [No Abstract]   [Full Text] [Related]  

  • 5. PHARMAC and statins--correction is needed.
    Metcalfe S; Moodie P
    N Z Med J; 2007 Mar; 120(1250):U2453. PubMed ID: 17339908
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosuvastatin in patients with elevated C-reactive protein.
    Mak KH; Chan ES
    N Engl J Med; 2009 Mar; 360(10):1039-40; author reply 1041-2. PubMed ID: 19271274
    [No Abstract]   [Full Text] [Related]  

  • 7. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
    Tonkin A; Barter P; Best J; Boyden A; Furler J; Hossack K; Sullivan D; Thompson P; Vale M; Cooper C; Robinson M; Clune E; ;
    Heart Lung Circ; 2005 Dec; 14(4):275-91. PubMed ID: 16361000
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. Treating cholesterol in patients with mild kidney disease.
    Ann Intern Med; 2003 Jan; 138(2):I28. PubMed ID: 12529112
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypothyroidism, pravastatin therapy and myopathy].
    Porela P; Kantola I
    Duodecim; 2002; 118(7):689-90. PubMed ID: 12238178
    [No Abstract]   [Full Text] [Related]  

  • 10. [2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone].
    Eklund K; Grip L; Israelsson B; Levin LA; Lindahl B; Wallentin L
    Lakartidningen; 2008 May 7-13; 105(19):1408-9; discussion 1409. PubMed ID: 18574983
    [No Abstract]   [Full Text] [Related]  

  • 11. The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: not all of them can afford it.
    Isma'eel H; Mohanna Z; Hamadeh G; Alam E; Badr K; Alam S; Rebeiz A
    Int J Cardiol; 2012 Mar; 155(2):316-8. PubMed ID: 22217486
    [No Abstract]   [Full Text] [Related]  

  • 12. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
    Friedewald VE; Ballantyne CM; Davidson MH; Guyton JR; Roberts WC
    Am J Cardiol; 2008 Sep; 102(5):559-67. PubMed ID: 18721512
    [No Abstract]   [Full Text] [Related]  

  • 13. Does higher usage of low-cost statins correlate with a poorer achievement in cholesterol quality markers for secondary prevention?
    Hickman J
    Br J Gen Pract; 2010 Jan; 60(570):50-2. PubMed ID: 20040169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention with over-the-counter statins: a cautionary tale.
    Davidoff F
    Clin Pharmacol Ther; 2005 Sep; 78(3):218-20. PubMed ID: 16153392
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    Tsubokura M; Kami M
    N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins and colorectal cancer: the jury is still out.
    Goldstein MR; Mascitelli L; Pezzetta F
    Am J Gastroenterol; 2009 Nov; 104(11):2858-9. PubMed ID: 19888248
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins as novel therapies for osteoporosis?
    Galloway P; Greer IA; Sattar N
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):4-5. PubMed ID: 11803091
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer, lower, better? Lipid drugs and cardiovascular disease--the continuing story.
    Wierzbicki AS
    Int J Clin Pract; 2007 Jul; 61(7):1064-7. PubMed ID: 17577288
    [No Abstract]   [Full Text] [Related]  

  • 19. Over-the-counter statins.
    Aslam F
    Lancet; 2004 Jul 31-Aug 6; 364(9432):411-2. PubMed ID: 15288727
    [No Abstract]   [Full Text] [Related]  

  • 20. The paradigm of stains: will the lower cost of generics translate into health gains?
    Seabra-Gomes R
    Rev Port Cardiol; 2007 May; 26(5):497-501. PubMed ID: 17691276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.